{"id":28741,"date":"2026-04-13T19:13:38","date_gmt":"2026-04-13T17:13:38","guid":{"rendered":"https:\/\/mon.uvic.cat\/butlleti-recerca\/?p=28741"},"modified":"2026-04-20T16:06:25","modified_gmt":"2026-04-20T14:06:25","slug":"real-world-data-generation-with-elranatamab-in-relapsed-refractory-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/mon.uvic.cat\/butlleti-recerca\/2026\/04\/13\/real-world-data-generation-with-elranatamab-in-relapsed-refractory-multiple-myeloma\/","title":{"rendered":"Real-World Data Generation with Elranatamab in Relapsed\/Refractory Multiple Myeloma"},"content":{"rendered":"<p><a href=\"https:\/\/cdn.pfizer.com\/pfizercom\/2026-03\/2026-ONC-RRMM-ES-RES.pdf\">Real-World Data Generation with Elranatamab in Relapsed\/Refractory Multiple Myeloma<\/a><br \/>\n<strong>Convoca<\/strong>: Pfizer Inc<br \/>\n<strong>Termini<\/strong>: 22\/05\/2026<\/p>\n<p>Projects should focus on:<\/p>\n<ul>\n<li>Safety and efficacy of elranatamab in the context of real\u2011world use<\/li>\n<li>Outpatient administration of elranatamab and alternative CRS\/ICANS mitigation strategies<\/li>\n<li>Impact of prior treatments (BsAb, ADC) on elranatamab outcomes, and wash\u2011out period between treatments<\/li>\n<li>Clinical outcomes of elranatamab according to treatment sequencing for RRMM<\/li>\n<li>Collection and assessment of PROs, caregiver burden, and treatment\/prophylaxis adherence<\/li>\n<li>Infection patterns, timing, types, and management strategies, including Ig replacement therapy (IV and\/or SQ) while on elranatamab treatment<\/li>\n<li>Assessment of elranatamab use and outcomes across patient subgroups under\u2011represented in clinical trials (e.g., elderly patients, those with renal impairment)<\/li>\n<li>Characterizing clinical and biological determinants of response to elranatamab, including features associated with primary refractoriness, early versus delayed response, and disease relapse, as well as the identification and validation of predictive and response biomarkers<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Real-World Data Generation with Elranatamab in Relapsed\/Refractory Multiple Myeloma Convoca: Pfizer Inc Termini: 22\/05\/2026 Projects should focus on: Safety and &hellip; <a href=\"https:\/\/mon.uvic.cat\/butlleti-recerca\/2026\/04\/13\/real-world-data-generation-with-elranatamab-in-relapsed-refractory-multiple-myeloma\/\">Read More<\/a><\/p>\n","protected":false},"author":430,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[40,37,38,7],"tags":[],"class_list":["post-28741","post","type-post","status-publish","format-standard","hentry","category-convocatories-enginyeries","category-convocatories-ciencies","category-convocatories-salut","category-convocatories-obertes"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paCdMn-7tz","publishpress_future_action":{"enabled":true,"date":"2026-05-22 23:59:00","action":"change-status","newStatus":"trash","terms":[0],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/posts\/28741","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/users\/430"}],"replies":[{"embeddable":true,"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/comments?post=28741"}],"version-history":[{"count":2,"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/posts\/28741\/revisions"}],"predecessor-version":[{"id":28743,"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/posts\/28741\/revisions\/28743"}],"wp:attachment":[{"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/media?parent=28741"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/categories?post=28741"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mon.uvic.cat\/butlleti-recerca\/wp-json\/wp\/v2\/tags?post=28741"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}